Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Turki

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2009
Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from TunisiaO Abida, M Kallel-Sellami, P Joly, et al.
Dermatology (Basel, Switzerland)|September 21, 2013
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosisC Paul, D Coustou, M Lahfa, et al.
The British Journal of Dermatology|September 15, 2007
PTPN22 R620W polymorphism is not associated with pemphigusK Mejri, M Kallel-Sellami, E Petit-Teixeira, et al.
The British Journal of Dermatology|May 7, 2009
TRAF1/C5 polymorphism is not associated with pemphigusK Mejri, H Mbarek, M Kallel-Sellami, et al.
International Journal of Pharmaceutics|October 29, 2024
Vasculo-osteogenic keratin-based nanofibers containing merwinite nanoparticles and sildenafil for bone tissue regenerationBasma Talib Al-Sudani, Mastafa H Al-Musawi, Marwa M Kamil, et al.
The British Journal of Dermatology|February 16, 2007
Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasisM Kallel Sellami, M Zitouni, W Tombari, et al.
Clinical and Experimental Immunology|June 16, 2004
Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceusM Kallel Sellami, M Ben Ayed, H Mouquet, et al.
The British Journal of Dermatology|June 3, 2009
Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective allelesO Abida, M Zitouni, M Kallel-Sellami, et al.
La Tunisie Medicale|June 1, 2026
STSM 2025 & 2nd African Medical Writing CongressN Adaily, A Abbassi, M Abbes, et al.
La Tunisie Medicale|September 8, 2023
2022 TUNISIAN NATIONAL CONGRESS OF MEDICINE ABSTRACTSA Yacoub, A Ayadi, W Ayed, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2009
Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from TunisiaO Abida, M Kallel-Sellami, P Joly, et al.
Dermatology (Basel, Switzerland)|September 21, 2013
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosisC Paul, D Coustou, M Lahfa, et al.
The British Journal of Dermatology|September 15, 2007
PTPN22 R620W polymorphism is not associated with pemphigusK Mejri, M Kallel-Sellami, E Petit-Teixeira, et al.
The British Journal of Dermatology|May 7, 2009
TRAF1/C5 polymorphism is not associated with pemphigusK Mejri, H Mbarek, M Kallel-Sellami, et al.
International Journal of Pharmaceutics|October 29, 2024
Vasculo-osteogenic keratin-based nanofibers containing merwinite nanoparticles and sildenafil for bone tissue regenerationBasma Talib Al-Sudani, Mastafa H Al-Musawi, Marwa M Kamil, et al.
The British Journal of Dermatology|February 16, 2007
Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasisM Kallel Sellami, M Zitouni, W Tombari, et al.
Clinical and Experimental Immunology|June 16, 2004
Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceusM Kallel Sellami, M Ben Ayed, H Mouquet, et al.
The British Journal of Dermatology|June 3, 2009
Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective allelesO Abida, M Zitouni, M Kallel-Sellami, et al.
La Tunisie Medicale|June 1, 2026
STSM 2025 & 2nd African Medical Writing CongressN Adaily, A Abbassi, M Abbes, et al.
La Tunisie Medicale|September 8, 2023
2022 TUNISIAN NATIONAL CONGRESS OF MEDICINE ABSTRACTSA Yacoub, A Ayadi, W Ayed, et al.
Pageof 15